actbiotechАктуальная биотехнологияTopical biotechnology2304-4691ВГУИТ10.20914/2304-4691-2019-3-398-401actbiotech-4296Research ArticleСтатьиАНАЛИЗ АНТИМИКРОБНОЙ И ГЕМОЛИТИЧЕСКОЙ АКТИВНОСТИ ПРЕПАРАТОВ, СОДЕРЖАЩИХ ИОННОЕ СЕРЕБРО ИЛИ НАНОЧАСТИЦЫ СЕРЕБРАВладимироваЕ. В.noemail@neicon.ruОрловД. С.noemail@neicon.ruУльяноваН. Ю.noemail@neicon.ruИванченкоО. Б.noemail@neicon.ruСанкт-Петербургский политехнический университет Петра ВеликогоRussian FederationИнститут экспериментальной медициныRussian FederationИнститут Химии силикатов им. А.В. Гребенщикова РАНRussian Federation20191809201903398401Copyright © Владимирова Е.В., Орлов Д.С., Ульянова Н.Ю., Иванченко О.Б., 20192019Владимирова Е.В., Орлов Д.С., Ульянова Н.Ю., Иванченко О.Б.Владимирова Е.В., Орлов Д.С., Ульянова Н.Ю., Иванченко О.Б.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.actbio-vsuet.ru/jour/article/view/4296ReferencesLewies A., Du Plessis L.H., Wentzel J.F. Antimicrobial Peptides: the Achilles’ Heel of Antibiotic Resistance? //Probiotics and antimicrobial proteins. - 2019. - V. 11, №. 2. - P. 370-381.Lewies A., Du Plessis L.H., Wentzel J.F. Antimicrobial Peptides: the Achilles’ Heel of Antibiotic Resistance? //Probiotics and antimicrobial proteins. - 2019. - V. 11, №. 2. - P. 370-381.Rai M.K. et al. Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria //Journal of applied microbiology. - 2012. - V. 112, № 5. - P.841-52.Rai M.K. et al. Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria //Journal of applied microbiology. - 2012. - V. 112, № 5. - P.841-52.Lara H.H. et al. Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds //Journal of nanobiotechnology. - 2011. - V.9. - E.30.Lara H.H. et al. Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds //Journal of nanobiotechnology. - 2011. - V.9. - E.30.Kim J.S. et al. Antimicrobial effects of silver nanoparticles //Nanomedicine: Nanotechnology, Biology and Medicine. - 2007. - V.3. - P. 95-101.Kim J.S. et al. Antimicrobial effects of silver nanoparticles //Nanomedicine: Nanotechnology, Biology and Medicine. - 2007. - V.3. - P. 95-101.Jung W.K. et al. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli //Appl. Environ. Microbiol. - 2008. - V. 74, №. 7. - P. 2171-2178.Jung W.K. et al. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli //Appl. Environ. Microbiol. - 2008. - V. 74, №. 7. - P. 2171-2178.Durán N. et al. Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action //Journal of the Brazilian Chemical Society. - 2010. - V.21, № 6. - P.949-959.Durán N. et al. Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action //Journal of the Brazilian Chemical Society. - 2010. - V.21, № 6. - P.949-959.Durek A. et al. New antibacterial therapeutics and strategies //Pol J Microbiol. - 2011. - V. 60, № 1. - P.3-12.Durek A. et al. New antibacterial therapeutics and strategies //Pol J Microbiol. - 2011. - V. 60, № 1. - P.3-12.Park E.J. et al. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism // Toxicology in vitro. - 2010. - V. 24, № 23, - P. 872-878.Park E.J. et al. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism // Toxicology in vitro. - 2010. - V. 24, № 23, - P. 872-878.Shafer W.M. (ed.). Antibacterial peptide protocols. - Humana Press, 1997. - V. 78. - 255 p.Shafer W.M. (ed.). Antibacterial peptide protocols. - Humana Press, 1997. - V. 78. - 255 p.
The authors declare that there are no conflicts of interest present.